Home›Triptorelin›Legal status
Educational — Not Legal AdviceReviewed
Is Triptorelin legal? FDA status and US regulatory standing
Current status
FDA-approved. Triptorelin is an FDA-approved drug (status recorded ).
Primary source: www.accessdata.fda.gov
Federal legal status
FDA approval status
Triptorelin is an FDA-approved drug. FDA-approved GnRH agonist. Brand: Trelstar (NDA 020726, Jun 2000). Indicated for advanced prostate cancer. Also used off-label for precocious puberty and chemical castration. Prescription only.
Also known as
Decapeptyl · Trelstar · GnRH agonist
Status history
- Triptorelin is an FDA-approved drug. [source]
Frequently asked questions
- Is Triptorelin FDA approved?
- Triptorelin is an FDA-approved drug (status recorded 2000-06-15). Primary source linked on this page.
- Can doctors prescribe Triptorelin?
- Triptorelin is listed as prescription-availability in the PeptideBase library. Prescribing rules vary by state and prescriber licensure — consult a licensed clinician.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .